Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advancing Nanoparticle Technology Creating Opportunities for Drug Developers; New Survey by Greystone Associates Examines Technology, Therapeutic and Market Factors.


AMHERST, N.H. -- Advances in nanotechnology that enable drugs to be delivered in ways that preserve their efficacy and to precise therapeutic targets are creating a host of opportunities for drug developers. A variety of nanostructures are being investigated as functional drug carriers for a wide range of therapies, most notably cardiovascular medicine, autoimmune diseases Autoimmune diseases
A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs.

Mentioned in: Complement Deficiencies, Premature Menopause
, and cancer.

"While the concept of nanoparticles in drug delivery is not new, the number of research programs and active drug development projects has escalated as funding to nanotechnology developers has increased," explains George Perros, Greystone Managing Director. "The result is the emergence of a host of novel nanotechnologies tailored to meet the physicochemical physicochemical /phys·i·co·chem·i·cal/ (fiz?i-ko-kem´ik-il) pertaining to both physics and chemistry.

phys·i·co·chem·i·cal
adj.
1. Relating to both physical and chemical properties.
 requirements of drug developers."

Nanoparticles have already improved the availability and efficacy of some drugs, but the capabilities that evolving technologies possess will leads to a dramatic increase in the number of therapies delivered via nanoparticles. In many cases drugs in nanocrystalline form can be administered in smaller doses because they can be delivered directly to the tissue and in controlled doses related to the patient's personal requirements.

These findings are contained in a new and comprehensive report: Nanoparticle Drug Delivery: Technology, Therapies, and Prospects. The survey concludes that nanoparticle-based drug delivery will gain traction Traction Definition

Traction is the use of a pulling force to treat muscle and skeleton disorders.
Purpose

Traction is usually applied to the arms and legs, the neck, the backbone, or the pelvis.
 at the expense of traditional drug formulation formulation /for·mu·la·tion/ (for?mu-la´shun) the act or product of formulating.

American Law Institute Formulation
 methods, particularly among emerging biologics.

More information is available at www.greystoneassociates.org.

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee
consulting company

business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a
 providing services in strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , venture development, product commercialization, and technology and market assessment.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 24, 2005
Words:250
Previous Article:Midsize Law Firm, Sussman Shank, Selects InterAction for CRM.
Next Article:Cymfony Launches Digital Consumer Insight to Analyze Blogs, Message Boards and Other Consumer-Generated Media for Market Intelligence.



Related Articles
Investment strategy for property development.
Therapeutic recreation programs for adolescents in substance abuse treatment facilities.
Oral Drug Delivery Keeping Pace with Emerging Technologies; New Survey by Greystone Associates Finds Tech Advances Key to New Dosage Forms.
Noninvasive Technologies Becoming a Key Element in Pharmaceutical Strategies.
Release Technology Yielding Tailorable Oral Drugs; New Survey by Greystone Associates Finds Tech Advances Key to New Dosage Forms.
Growth in Transmucosal Drug Delivery Driven by Demographic, Healthcare Trends.
Are Coated Devices the Future of Interventional Therapeutics? New Survey by Greystone Associates Examines Potential for Drug-Coated Devices.
As Patient Benefits Become Clear, Multi-Drug Delivery Systems Gain Momentum; New Survey by Greystone Associates Examines Technology and Therapeutic...
Major Deals Changing the Landscape for Needle-free Injection.
Despite Limitations, the Lure of Transdermal Skin Patches Remains Strong.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles